Vikas Sharma, Ph.D.
Vice President of Business Development, BioXcel Therapeutics
Dr. Sharma has over 12 years of experience in business development activities across the pharma landscape. He has led multiple complex deals that involved upfront, milestone and royalty payments. He is currently the Vice President of Business Development for BioXcel Therapeutics, a clinical stage biopharmaceutical development company utilizing novel artificial intelligence approaches to identify the next wave of medicines across neuroscience and immuno-oncology. Dr. Sharma leads BioXcel’s strategic business development initiatives including global licensing and partnerships for lead assets as well as emerging pipeline.
Most recently Dr. Sharma was the Director of Business Development at MacroGenics where he played an instrumental role in leading licensing deals with companies such as Incyte Corporation, Roche, and Janssen Pharmaceuticals. Prior to joining MacroGenics, Dr. Sharma served as the Director of Business Development at Rexahn Pharmaceuticals where he led the due diligence and execution of licensing deals, M&A as well as capital markets transactions. Previously, he served as Manager of Business Development for MedImmune (the global biologics business of AstraZeneca), where he executed multiple licensing transactions. Prior to that, Dr. Sharma served in a business development role with increasing responsibilities at Children’s Hospital of Philadelphia, Bradley Pharmaceuticals and Advanced Bioadjuvant.
Dr. Sharma earned his doctorate and master’s degree in biology from Rutgers University. Dr. Sharma has authored multiple peer-reviewed publications and conference presentations.